{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:28:26Z","timestamp":1787012906128,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["ME-2020C3-21145"],"award-info":[{"award-number":["ME-2020C3-21145"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH126856"],"award-info":[{"award-number":["R01MH126856"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"DOI":"10.1186\/s12888-026-08159-x","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T11:25:04Z","timestamp":1779708304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of antidepressants for depression using EHRs from two health systems"],"prefix":"10.1186","volume":"26","author":[{"given":"Hwanhee","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungeun","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Badillo","family":"Goicoechea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly L.","family":"Brantner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace V.","family":"Ringlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane P.","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando S.","family":"Goes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"8 Suppl 13","key":"8159_CR1","first-page":"1","volume":"12","author":"MH Trivedi","year":"2007","unstructured":"Trivedi MH, Lin E, Katon WJ. Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression. CNS Spectr. 2007;12(8 Suppl 13):1\u201327.","journal-title":"CNS Spectr"},{"key":"8159_CR2","unstructured":"Depressive disorder (depression). WHO. Updated March 31. 2023. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/depression. Accessed 21 Apr 2025."},{"issue":"2","key":"8159_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.7326\/M22-1845","volume":"176","author":"G Gartlehner","year":"2023","unstructured":"Gartlehner G, Dobrescu A, Chapman A, et al. Nonpharmacologic and pharmacologic treatments of adult patients with major depressive disorder: a systematic review and network meta-analysis for a clinical guideline by the American College of Physicians. Ann Intern Med. 2023;176(2):196\u2013211.","journal-title":"Ann Intern Med"},{"issue":"3","key":"8159_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/fampra\/cmad061","volume":"41","author":"KH Patel","year":"2024","unstructured":"Patel KH, Chrisinger B. Effectiveness of primary care interventions in conjointly treating comorbid chronic pain and depression: a systematic review and meta-analysis. Fam Pract. 2024;41(3):234\u201345.","journal-title":"Fam Pract"},{"issue":"23","key":"8159_CR5","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1001\/jama.2023.9297","volume":"329","author":"MJ Barry","year":"2023","unstructured":"Barry MJ, Nicholson WK, Silverstein M, et al. Screening for depression and suicide risk in adults: US Preventive Services Task Force recommendation statement. JAMA. 2023;329(23):2057\u201367.","journal-title":"JAMA"},{"issue":"4","key":"8159_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1176\/appi.focus.16407","volume":"16","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Focus. 2018;16(4):420\u20139.","journal-title":"Focus"},{"issue":"2","key":"8159_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2147\/nedt.2007.3.2.193","volume":"3","author":"DJ Goldstein","year":"2007","unstructured":"Goldstein DJ. Duloxetine in the treatment of major depressive disorder. Neuropsychiatr Dis Treat. 2007;3(2):193\u2013209.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"8159_CR8","doi-asserted-by":"publisher","first-page":"554899","DOI":"10.3389\/fpsyt.2020.554899","volume":"11","author":"D Rodrigues-Amorim","year":"2020","unstructured":"Rodrigues-Amorim D, Olivares JM, Spuch C, Rivera-Baltan\u00e1s T. A systematic review of efficacy, safety, and tolerability of duloxetine. Front Psychiatry. 2020;11:554899.","journal-title":"Front Psychiatry"},{"issue":"12","key":"8159_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/ijnp\/pyac054","volume":"25","author":"I-C Huang","year":"2022","unstructured":"Huang I-C, Chang T-S, Chen C, Sung J-Y. Effect of vortioxetine on cognitive impairment in patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol. 2022;25(12):969\u201378.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8159_CR10","doi-asserted-by":"publisher","first-page":"922648","DOI":"10.3389\/fpsyt.2022.922648","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Cai Y, Hu X, Lu CY, Nie X, Shi L. Systematic review and meta-analysis of vortioxetine for the treatment of major depressive disorder in adults. Front Psychiatry. 2022;13:922648.","journal-title":"Front Psychiatry"},{"issue":"6","key":"8159_CR11","first-page":"1099","volume":"72","author":"C Cobb","year":"2005","unstructured":"Cobb C, Crichlow R. Duloxetine (Cymbalta) for treatment of major depressive disorder. Am Family Phys. 2005;72(6):1099\u2013101.","journal-title":"Am Family Phys"},{"issue":"5","key":"8159_CR12","first-page":"325","volume":"91","author":"MK Magovern","year":"2015","unstructured":"Magovern MK, Degeorge KC. Vortioxetine (brintellix) for the treatment of depression. Am Family Phys. 2015;91(5):325\u20136.","journal-title":"Am Family Phys"},{"issue":"7","key":"8159_CR13","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.euroneuro.2011.11.008","volume":"22","author":"DS Baldwin","year":"2012","unstructured":"Baldwin DS, Loft H, Dragheim M. A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD). Eur Neuropsychopharmacol. 2012;22(7):482\u201391.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"8159_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/YIC.0000000000000018","volume":"29","author":"J-P Boulenger","year":"2014","unstructured":"Boulenger J-P, Loft H, Olsen CK. Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20\u00a0mg\/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder. Int Clin Psychopharmacol. 2014;29(3):138\u201349.","journal-title":"Int Clin Psychopharmacol"},{"issue":"3","key":"8159_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1185\/03007995.2012.761600","volume":"29","author":"AR Mahableshwarkar","year":"2013","unstructured":"Mahableshwarkar AR, Jacobsen PL, Chen Y. A randomized, double-blind trial of 2.5\u00a0mg and 5\u00a0mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder. Curr Med Res Opin. 2013;29(3):217\u201326.","journal-title":"Curr Med Res Opin"},{"key":"8159_CR16","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1007\/s00213-014-3839-0","volume":"232","author":"AR Mahableshwarkar","year":"2015","unstructured":"Mahableshwarkar AR, Jacobsen PL, Chen Y, Serenko M, Trivedi MH. A randomized, double-blind, duloxetine-referenced study comparing efficacy and tolerability of 2 fixed doses of vortioxetine in the acute treatment of adults with MDD. Psychopharmacology. 2015;232:2061\u201370.","journal-title":"Psychopharmacology"},{"key":"8159_CR17","doi-asserted-by":"publisher","unstructured":"Brantner CL, Yu W, Zhao C, Jeon K, Ringlein GV, Wang Q, et al. The challenges of integrating diverse data sources: a case study in major depression. Health Serv Outcomes Res Methodol. 2025 https:\/\/doi.org\/10.1007\/s10742-025-00363-8","DOI":"10.1007\/s10742-025-00363-8"},{"issue":"8","key":"8159_CR18","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1524-4733.2009.00600.x","volume":"12","author":"ML Berger","year":"2009","unstructured":"Berger ML, Mamdani M, Atkins D, Johnson ML. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report\u2014Part I. Value health. 2009;12(8):1044\u201352.","journal-title":"Value health"},{"issue":"1","key":"8159_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s13018-023-03995-z","volume":"18","author":"F Migliorini","year":"2023","unstructured":"Migliorini F, Maffulli N, Eschweiler J, Baroncini A, Bell A, Colarossi G. Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis. J Orthop Surg Res. 2023;18(1):504.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"8159_CR20","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12891-023-06488-6","volume":"24","author":"X Ma","year":"2023","unstructured":"Ma X, Zhou S, Sun W, et al. Efficacy and safety of duloxetine in chronic musculoskeletal pain: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2023;24(1):394.","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"8159_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"4","key":"8159_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1177\/2150131916656155","volume":"7","author":"K Abernathy","year":"2016","unstructured":"Abernathy K, Zhang J, Mauldin P, et al. Acute care utilization in patients with concurrent mental health and complex chronic medical conditions. J Prim Care Community Health. 2016;7(4):226\u201333.","journal-title":"J Prim Care Community Health"},{"issue":"4","key":"8159_CR23","doi-asserted-by":"publisher","first-page":"e0266605","DOI":"10.1371\/journal.pone.0266605","volume":"17","author":"M Cicek","year":"2022","unstructured":"Cicek M, Hayhoe B, Otis M, Nicholls D, Majeed A, Greenfield G. Depression and unplanned secondary healthcare use in patients with multimorbidity: A systematic review. PLoS ONE. 2022;17(4):e0266605.","journal-title":"PLoS ONE"},{"issue":"26","key":"8159_CR24","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJ Kind","year":"2018","unstructured":"Kind AJ, Buckingham WR. Making neighborhood-disadvantage metrics accessible\u2014the neighborhood atlas. N Engl J Med. 2018;378(26):2456.","journal-title":"N Engl J Med"},{"issue":"1","key":"8159_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327.","journal-title":"Med Care"},{"issue":"23","key":"8159_CR26","doi-asserted-by":"publisher","first-page":"648","DOI":"10.21105\/joss.00648","volume":"3","author":"A Gasparini","year":"2018","unstructured":"Gasparini A. Comorbidity: an R package for computing comorbidity scores. J Open Source Softw. 2018;3(23):648.","journal-title":"J Open Source Softw"},{"issue":"1","key":"8159_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41\u201355.","journal-title":"Biometrika"},{"issue":"25","key":"8159_CR28","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med"},{"issue":"19","key":"8159_CR29","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1002\/sim.1903","volume":"23","author":"JK Lunceford","year":"2004","unstructured":"Lunceford JK, Davidian M. Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med. 2004;23(19):2937\u201360.","journal-title":"Stat Med"},{"key":"8159_CR30","unstructured":"Zhou T, Tong G, Li F, Thomas LE. PSweight: an R package for propensity score weighting analysis. 2020. arXiv preprint arXiv:201008893."},{"key":"8159_CR31","doi-asserted-by":"crossref","unstructured":"James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning. Springer. 2013;112.","DOI":"10.1007\/978-1-4614-7138-7"},{"issue":"1","key":"8159_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.5334\/egems.243","volume":"5","author":"M Phelan","year":"2017","unstructured":"Phelan M, Bhavsar NA, Goldstein BA. Illustrating informed presence bias in electronic health records data: how patient interactions with a health system can impact inference. EGEMs. 2017;5(1):22.","journal-title":"EGEMs"},{"key":"8159_CR33","unstructured":"McMahan B, Moore E, Ramage D, Hampson SY, Arcas BA. Communication-efficient learning of deep networks from decentralized data. PMLR. 2017:1273\u20131282."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08159-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:21:43Z","timestamp":1787012503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08159-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8159"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08159-x","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval of the study was obtained from the Duke IRB (Pro00108971) and the Johns Hopkins University IRB (IRB0017538). Because this was a retrospective data analysis, informed consent from participants was not required. All study procedures were conducted in accordance with relevant ethical guidelines and regulations, adhering to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"638"}}